在同时患有视力障碍和痴呆症的人身上应用认知刺激疗法 (CST):初步研究
Hiu Tung Tsang1, Chun Lam Luk1, Yee Lam Lo2
1Academic Unit of Human Communication, Learning, and Development, Faculty of Education, The University of Hong Kong, Hong Kong SAR, China.
Brain sciences
|February 27, 2026
概括
认知刺激疗法 (CST) 对患有痴呆症和视力障碍的老年人来说是有前途的. 在试点研究中,在小组治疗课程后观察到显著的认知和语言改善.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 眼科医生 眼科 眼科
背景情况:
- 痴呆症会影响老年人,通常与视力障碍同时发生.
- 认知刺激疗法 (CST) 是一种基于证据的治疗轻度至中度痴呆症的干预方法.
研究的目的:
- 评估CST在老年人同时患有痴呆症和视力障碍的适用性.
- 评估该人群中CST的初步临床结果.
主要方法:
- 一项试点研究涉及七名患有痴呆症和视力障碍的老年参与者.
- 参与者接受了认知刺激疗法 (CST) 的14个小组会议.
- 在治疗干预之前和之后评估认知和语言功能.
主要成果:
- 参与者对治疗的坚持是令人满意的.
- 在治疗后的各种认知领域观察到显著的改善.
- 在CST.ST之后的语言指标中发现了积极的变化.
结论:
- CST似乎适用于患有痴呆症的视力障碍者.
- 初步发现表明,这一群体在认知领域的积极结果.
- 建议使用更大的样本和多感官方法进行进一步的研究.
相关概念视频
Cognitive Development During Adulthood
988
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
988
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K


